GeneThera Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project
October 12, 2021 09:00 ET
|
GeneThera Inc.
WESTMINSTER, Colo., Oct. 12, 2021 (GLOBE NEWSWIRE) -- GeneThera, Inc. (OTCMKT: GTHR) announced today that it has entered into an exclusive agreement with Cushman & Wakefield (NYSE:CWK) to...
GeneThera Inc. Expands Its Operation in the United Kingdom
May 18, 2021 07:00 ET
|
GeneThera Inc.
WESTMINSTER, Colo., May 18, 2021 (GLOBE NEWSWIRE) -- GeneThera is pleased to announce that it has incorporated a subsidiary in the United Kingdom. GeneThera Robotics Ltd, a majority owned subsidiary...
GeneThera enters into a collaboration agreement with an International Construction Advisor Company to build a network of zoonotic diseases laboratory facilities
April 27, 2021 09:00 ET
|
GeneThera Inc.
WESTMINSTER, Colo., April 27, 2021 (GLOBE NEWSWIRE) -- GeneThera announced today that it has entered into a partnership agreement with Cumming Corporation, a privately held international project...
GeneThera’s Strategy for the Development of a Global Zoonotic Diseases Surveillance System Using Smart Testing Technology
April 13, 2021 09:00 ET
|
GeneThera Inc.
WESTMINSTER, Colo., April 13, 2021 (GLOBE NEWSWIRE) -- We are developing the infrastructure of a global zoonotic infectious diseases “alert shield” (ZIDAS) able to successfully manage and control...
GeneThera Technology Platform for Wastewater Testing: A More Effective Way to Control the COVID-19 Pandemic
April 06, 2021 09:00 ET
|
GeneThera Inc.
WESTMINSTER, Colo., April 06, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 pandemic has demonstrated that neither current systems or related technologies are capable of preventing or even...
GENETHERA APPOINTS SCIENTIFIC ADVISOR
February 24, 2016 09:38 ET
|
GeneThera
WESTMINSTER, Colo., Feb. 24, 2016 (GLOBE NEWSWIRE) -- GeneThera Inc. (OTC: GTHR). announced today that it has appointed Professor Karel Hruska as its Scientific Advisor. Professor Hruska was the...
GENETHERA SECURES NEW LABORATORY FACILITIES TO EXPAND TECHNOLOGY PLATFORMS
January 25, 2016 12:33 ET
|
GeneThera
WESTMINSTER, Colo., Jan. 25, 2016 (GLOBE NEWSWIRE) -- GeneThera Inc. (OTC: GTHR) announced today that it has secured a new laboratory facility. Dr. Tony Milici, CEO of GeneThera, stated; "This is an...
GENETHERA, INC. ISSUES COMMENTS ON THE FIRST INTERNATIONAL RESEARCH SYMPOSIUM ON MAP AND CROHN'S DISEASE.
September 29, 2015 09:43 ET
|
GeneThera
WESTMINSTER, Colo., Sept. 29, 2015 (GLOBE NEWSWIRE) -- GeneThera, Inc. (OTC: GTHR) as a service to its shareholders and the general public is pleased to release comments on the first Symposium on...
MYCOBACTERIUM AVIUM PARATUBERCULOSIS (MAP) INFECTION: THE GLOBAL WARMING OF THE CATTLE INDUSTRY
August 03, 2015 09:37 ET
|
GeneThera
WESTMINSTER, Colo., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Despite warnings from scientists who have shown unquestionable data that Earth climate has been changing due to human activities, governments and...
GENETHERA APPOINTS TWO NEW MEMBERS ON ITS BOARD OF DIRECTORS
April 21, 2015 11:54 ET
|
GeneThera
WESTMINSTER, Colo., April 21, 2015 (GLOBE NEWSWIRE) -- GeneThera Inc. (OTC:GTHR) announced today that has appointed Bruce Winsett and Jorgen Frandsen as members of the Company's Board of...